TIANSHENG PHARMACEUTICAL GROUP CO., LTD.

Tiansheng Pharmaceutical Group Co., Ltd.

002872

CNE100002QC3

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 27/05/2024 BST			5-day change	1st Jan Change
4.23 ^CNY	-1.63%		-2.31%	-17.54%

2023	Tiansheng Pharmaceutical Group Co., Ltd. Announces Executive Appointments	CI
2023	Tiansheng Pharmaceutical’s Paracetamol Tablet Passes Consistency Test	MT

Tiansheng Pharmaceutical Group Co., Ltd. Announces 2017 Final Distribution Plan, Payable on August 22, 2018

August 15, 2018 at 04:32 pm

Tiansheng Pharmaceutical Group Co., Ltd. announced implementation of final cash dividend (A shares) of CNY 2.36000000 per ten shares (tax included) for 2017. Record date will be August 21, 2018, ex-date will be August 22, 2018 and Payment date will be August 22, 2018.

Latest news about Tiansheng Pharmaceutical Group Co., Ltd.

Tiansheng Pharmaceutical Group Co., Ltd. Announces Executive Appointments	11-27	CI
Tiansheng Pharmaceutical’s Paracetamol Tablet Passes Consistency Test	11-17	MT
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23	CI
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23	CI
Tiansheng Pharmaceutical's Technology Center Named National Enterprise Technology Center	24/02/23	MT
Tiansheng Pharmaceutical Unit Gets Regulatory Approval for Injection	18/11/22	MT
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	24/10/22	CI
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	24/08/22	CI
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	24/04/22	CI
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	27/10/21	CI
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	26/08/21	CI
Chongqing Pharmaceutical CO., LTD. completed the acquisition of 51% stake in Chongqing Changsheng Medicine Co., Ltd. from Tiansheng Pharmaceutical Group Co., Ltd..	28/04/21	CI
Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	26/04/21	CI
Tiansheng Pharmaceutical Group Co., Ltd. Approves Election of Directors	14/12/20	CI
An unknown buyer acquired 11% stake in Hubei Xianming Medical Apparatus and Instruments Co., Ltd. from Hubei Xianming Medical Apparatus and Instruments Co., Ltd. for CNY 5.1 million.	04/11/20	CI
An unknown buyer acquired Chongqing Xinmei Pharmaceutical Co., Ltd. from Tiansheng Pharmaceutical Group Co., Ltd. for CNY 0.	04/11/20	CI
Chongqing Pharmaceutical CO., LTD. signed an equity transfer intention agreement to acquire 51% stake in Chongqing Changsheng Medicine Co., Ltd. from Tiansheng Pharmaceutical Group Co., Ltd. for CNY 59.6 million.	12/02/20	CI
Tiansheng Pharmaceutical Group Co., Ltd. cancelled the acquisition of Chongqing Dachuang Electrical Equipment Co., Ltd. from Chongqing Changlong Industrial Co., Ltd.	11/12/18	CI
Tiansheng Pharmaceutical Group Co., Ltd. cancelled the acquisition of Chongqing Junyao Pharmaceutical Packing Products Co., Ltd. from Chen Yi and Feng Yi.	17/09/18	CI
Tiansheng Pharmaceutical Group Co., Ltd. Announces 2017 Final Distribution Plan, Payable on August 22, 2018	15/08/18	CI
Tiansheng Pharmaceutical Approves the Cash Dividend for the Year 2017	27/06/18	CI
Tiansheng Pharmaceutical Proposes Final Dividend for the Year 2017	23/04/18	CI
Luzhou Tiansheng Pharmaceutical Co., Ltd. announced that it expects to receive CNY 150 million in funding from Tiansheng Pharmaceutical Group Co., Ltd.	12/02/18	CI
Tiansheng Pharmaceutical Group Co., Ltd. agreed to acquire Chongqing Dachuang Electrical Equipment Co., Ltd. from Chongqing Changlong Industrial Co., Ltd. for CNY 31 million.	12/12/17	CI
Tiansheng Pharmaceutical Group Co., Ltd. Forms Medical Appliances Joint Venture in Chongqing City, China	19/11/17	CI

Chart Tiansheng Pharmaceutical Group Co., Ltd.

Duration

Period

Chart Tiansheng Pharmaceutical Group Co., Ltd.

More charts

Company Profile

Tiansheng Pharmaceutical Group Co LTD is a China-based company principally engaged in the research and development, manufacture and sales of pharmaceuticals. The Company's main products include pediatric lung cough particles, erythromycin enteric-coated capsules, silver ginseng Tongluo capsules, Salvia granules, Shugan Yi spleen granules, compound Ganoderma lucidum granules, Xiangdan injection, Injection, Qi and Diabetes tablets, liver capsule, Ling Jing capsule, lungs of nuclear paste, Shen Qi Yi lung pill, among others. The Company mainly distributes its products within domestic market.

Sector

Pharmaceuticals

Calendar

22/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
TIANSHENG PHARMACEUTICAL GROUP CO., LTD.	-17.54%	189M
ELI LILLY AND COMPANY	+38.59%	727B
JOHNSON & JOHNSON	-7.89%	354B
MERCK & CO., INC.	+15.66%	328B
ABBVIE INC.	+0.24%	277B
ASTRAZENECA PLC	+13.47%	243B
NOVARTIS AG	+7.35%	205B
ROCHE HOLDING AG	-6.42%	203B
AMGEN INC.	+4.23%	164B
PFIZER, INC.	-1.70%	164B

Other Pharmaceuticals